CAT and metabolic dysfunction-associated steatotic liver disease: To determine whether the protective effects of CAT against liver steatosis were autophagy-dependent, an invitro model of NAFLD was established by treating HepG2 cells with PA for 24 h (Supplementary Figures 3A, 4B).